GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiangxue Pharmaceutical Co Ltd (SZSE:300147) » Definitions » EPS (Basic)

Xiangxue Pharmaceutical Co (SZSE:300147) EPS (Basic) : ¥-0.70 (TTM As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Xiangxue Pharmaceutical Co EPS (Basic)?

Xiangxue Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was ¥-0.13. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.70.

Xiangxue Pharmaceutical Co's EPS (Diluted) for the three months ended in Sep. 2024 was ¥-0.13. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.70.

Xiangxue Pharmaceutical Co's EPS without NRI for the three months ended in Sep. 2024 was ¥-0.14. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -0.52.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Xiangxue Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 86.10% per year. The lowest was -150.50% per year. And the median was 10.20% per year.


Xiangxue Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Xiangxue Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiangxue Pharmaceutical Co EPS (Basic) Chart

Xiangxue Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.11 -1.02 -0.80 -0.59

Xiangxue Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.37 -0.05 -0.15 -0.13

Xiangxue Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Xiangxue Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-388.964-0)/659.261
=-0.59

Xiangxue Pharmaceutical Co's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-82.577-0)/627.769
=-0.13

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xiangxue Pharmaceutical Co  (SZSE:300147) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Xiangxue Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Xiangxue Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Xiangxue Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No 2 Jinfeng Road , Science City, Guangzhou Economic and Technological Development Z, Guangzhou, CHN, 510663
Xiangxue Pharmaceutical Co Ltd is a China-based company engages in the manufacture and distribution of pharmaceutical products. Its diversified healthcare portfolio includes Chinese Herbal Slices, TCM, Life Science, Biomedical Engineering health solutions (food and beverage), healthcare supplements and so on.
Executives
Huang Wei Hua Supervisors
Tan Wen Hui Director
Kang Zhi Ying Executives
Ceng Lun Executives
Liu Yan Executives
Lu Feng Executives
Xu Li Secretary, Director
Mo Zi Yu Supervisors
Mai Zhen Jiang Supervisors
Wang Yong Hui Directors, executives
He Tao Executives
Fang Wei Min Supervisors
Huang Bin Directors, Directors, and Executives
Wu Jun Executives
Chen Wen Jin Executives

Xiangxue Pharmaceutical Co Headlines

No Headlines